Lanreotide diTFA
Lanreotide diTFA, a cutting-edge biomedicine of novel nature, is deployed in the intricate realm of acromegaly, an enigmatic hormonal disorder marked by the unwarranted surge in growth hormone secretion. Through virtue of embodying the essence of a somatostatin analog, this wonder drug efficaciously curbs the exocrine release of growth hormone, thus serving as a catalyst in abating the diverse array of notabilities accompanying acromegaly.
Online Inquiry
| CAT# | R2026 |
| CAS | 1024499-83-9 |
| M.F/Formula | C58H71F6N11O14S2 |
| M.W/Mr. | 1324.37 |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Write a review
Ask a question
My Review for Lanreotide diTFA
Required fields are marked with *
×
Ask a Question for Lanreotide diTFA
Required fields are marked with *
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
